Squarepoint
APYX icon

Squarepoint’s Apyx Medical APYX Stock Holding History

Squarepoint’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Buy
+32,144
New +$127K ﹤0.01% 4136
2024
Q2 		– Sell
-76,118
Closed -$104K – 4024
2024
Q1 		$104K Sell
76,118
-49,258
-39% -$105K ﹤0.01% 3792
2023
Q4 		$328K Buy
125,376
+47,114
+60% +$114K ﹤0.01% 3293
2023
Q3 		$250K Buy
+78,262
New +$365K ﹤0.01% 3283
2019
Q4 		– Sell
-48,896
Closed -$331K – 2467
2019
Q3 		$331K Sell
48,896
-24,604
-33% -$175K ﹤0.01% 1846
2019
Q2 		$494K Buy
73,500
+9,458
+15% +$51.4K ﹤0.01% 1681
2019
Q1 		$404K Buy
+64,042
New +$495K ﹤0.01% 1597
2017
Q3 		– Sell
-10,800
Closed -$27K – 1601
2017
Q2 		$27K Sell
10,800
-9,000
-45% -$22.1K ﹤0.01% 1482
2017
Q1 		$53K Buy
+19,800
New +$65.7K ﹤0.01% 1458

Other funds holding APYX

RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Squarepoint's APYX Position: Q2 2026 in Review

Squarepoint opened a new position in Apyx Medical (APYX) in Q2 2026: 32,144 shares worth $144K. The stake represents ﹤0.01% of the portfolio and ranks #4136 among its holdings. This is a return to the name: Squarepoint previously reported a position in APYX as recently as Q1 2024.

Squarepoint first reported a position in APYX in Q1 2017 and has held it in 9 quarters since. The position peaked at $494K in Q2 2019. 68 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • Squarepoint held 32,144 shares of Apyx Medical worth $144K as of Q2 2026.
  • Apyx Medical was a new Squarepoint position in Q2 2026.
  • Apyx Medical made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4136 holding.
  • Squarepoint first reported a position in Apyx Medical in Q1 2017 and has held it in 9 quarters since.
  • Squarepoint's Apyx Medical position peaked at $494K in Q2 2019.
  • 68 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.